Expert Chaslau Koniukh
  • Companies
  • Global investment
  • Investors
  • Terminology
  • Economy
  • Stock Market
  • World exchanges
  • Tech and Marketing
atai life sciences
Stock Market

Startup ATAI Life Sciences plans an IPO

23.01.2022
2 min read

ATAI Life Sciences wants to go public on NASDAQ

Biopharmaceutical company ATAI Life Sciences is going public. It is planned to raise $100 million during the IPO. Now, private investors have invested more than $362 million in the startup. ATAI specializes in developing drugs based on psychedelic substances.
After the last funding round, the startup was valued at $2 billion, making it considered a “unicorn.”
According to the company’s plans, the NASDAQ stock exchange was chosen for the initial public offering, but the exact date of the IPO is not yet known. Major banks such as Credit Suisse and Citigroup are providing exit services.
The field of activity of ATAI is the production of drugs that help in treating depression, anxiety, phobias and other psychological problems.
As part of these drugs are psychoactive substances that affect the emotional state and perception of reality, changing it. The company employs 50 people who work in different cities. The main office is in Berlin, there are also offices in San Diego and New York. The drugs are being tested, but so far none of them has received approval from the regulatory authorities. Altogether, ATAI offers more than 10 drugs for various problems.
One of ATAI’s investors is Peter Thiel, who co-founded the PayPal payment system and has invested 10 million euros in the project through his own venture capital firm. According to Thiel, he became interested in ATAI because of their idea to help with mental disorders. The startup demonstrates the importance and seriousness of the problem by putting mental illnesses on a par with other diseases.ATAIATAI Life Sciences was founded in Germany in 2018; the company was one of the first on the market to start using psychedelics to treat psychiatric problems. To do this, the startup used a synthetic substitute for psilocybin, which is the main active ingredient of hallucinogenic mushrooms.
According to studies, more than 100 million people in the world suffer from various kinds of depressive disorders, for which traditional therapy is ineffective. ATAI aims to help these patients, and to do this, the experts are working on a study of the effects of psychedelics on mental states.
In the structure of ATAI there are 11 projects, which are engaged in research and search of new methods of treatment of various mental illnesses. The results of the company’s activities are already visible, the drugs are being tested and show good progress in patients. Investors consider the startup promising, and investments are growing, despite psilocybin’s dubious reputation. Its effects have not been fully investigated, which prevents widespread use for medical purposes.

Tags: Stock Market
0
Previous Post Japan invests in the development of hydrogen energy Next Post BlackRock analysts: global ETFs are actively developing

You Might Also Like

SPAC companies
Stock Market
SPAC-companies may appear in Russia by the end of 2022
04.03.2022
Perpetual bonds
Stock Market
Perpetual bonds from the Russian Post: why do you need to issue bonds?
09.03.2021
Ruble rate fluctuation
Stock Market
Ruble exchange rate fluctuation: how to preserve savings in an unstable national currency
12.06.2020
Gold_Russia
Stock Market
Gold reserves in Russia are declining: the factors that affect the movement of the asset
25.09.2021
billionaire woman
Stock Market
First female billionaire from Africa: professional plans related to the Russian market
31.08.2020
Placement of eurobonds
Stock Market
Lithuania announced Eurobonds placement to stabilize economy
08.01.2021

Recent Posts

  • 1reduction in investment
    German business expects reduction in investment: survey
    26.05.2022
  • 2guidelines for cryptocurrency exchanges
    Canada releases guidelines for cryptocurrency exchanges
    25.05.2022
  • 3How IT is used in banks
    How IT in banks helps transform the sector
    24.05.2022
  • 4Development of the financial sector-1
    Development of the financial sector in terms of DeFi potential
    23.05.2022
  • 5export volumes
    India’s export volumes rise to record levels
    22.05.2022

Popular Posts

  • Skolkovo analysts: the Russian energy market is suffering losses
  • Businessman Chuck Feeney: the man who gave the world Duty Free
  • Field of activity of the American Monsanto Company Corporation
  • Is the oil market waiting for another collapse of quotations: the opinion of a LUKOIL analyst?

Social media

Editor's Picks

Chaslau Koniukh
Analytics

American bankers from JPMorgan and Goldman Sachs advise to invest in gold: review by Chaslau Koniukh.

Press Secretary
17.08.2020
Expert Chaslau Koniukh
Analytics

Chaslau Koniukh on the analysts’ opinion on the key stake size change soon

Press Secretary
18.06.2020
expert Chaslau Koniukh
Analytics

Chaslau Koniukh: Internet trade market in Russia may reach 2.78 trillion rubles.

Press Secretary
30.05.2020
Will the U.S. oil shale industry be able to quickly recover from the crisis: A Review by Chaslau Koniukh
Analytics

Will the U.S. oil shale industry be able to quickly recover from the crisis: A Review by Chaslau Koniukh

Press Secretary
16.05.2020

Latest Posts

reduction in investment
German business expects reduction in investment: survey
26.05.2022
guidelines for cryptocurrency exchanges
Canada releases guidelines for cryptocurrency exchanges
25.05.2022
How IT is used in banks
How IT in banks helps transform the sector
24.05.2022

Chaslau Koniukh

Expert Chaslau Koniukh

Chaslau Koniukh – an expert in marketing and project management, IT consulting, international investments, investor, financial analyst. A commodity trader, private consultant, entrepreneur, lecturer, author of several articles on the stock market.

Popular Posts

  • Skolkovo analysts: the Russian energy market is suffering losses
  • Businessman Chuck Feeney: the man who gave the world Duty Free
  • Field of activity of the American Monsanto Company Corporation
  • Is the oil market waiting for another collapse of quotations: the opinion of a LUKOIL analyst?
  • US economic growth rate: forecast for the coming year
Expert Chaslau Koniukh
  • Facebook
  • Twitter
  • Instagram
  • Biography

Chaslau Koniukh – an expert in marketing and project management, international investments, financial analyst.

Social media

Menu

  • Biography
  • Companies and corporations
  • Global investment
  • Investors and Entrepreneurs
  • Economy
  • Market terminology
  • Stock Market
  • World exchanges
  • Tech and Marketing
  • Analytics